1-3 of 3
Jennifer Amengual
Close
Sort by
Journal Articles

Validation of a Novel Bioluminescent Mouse Model of Sezary Syndrome for Preclinical Drug Screening

Salvia Jain, MD, Luigi Scotto, Ph.D., Enrica Marchi, MD, Ph.D., Matko Kalac, MD, Ph.D., Jennifer Amengual, M.D., Jairo Baquero Buitrago, Owen A. O'Connor, MD, PhD
Journal: Blood
Blood (2011) 118 (21): 2725.
https://doi.org/10.1182/blood.V118.21.2725.2725
Published: 2011
Journal Articles

HDAC inhibitors and decitabine are highly synergistic and associated with unique gene-expression and epigenetic profiles in models of DLBCL

Matko Kalac, Luigi Scotto, Enrica Marchi, Jennifer Amengual, Venkatraman E. Seshan, Govind Bhagat, Netha Ulahannan, Violetta V. Leshchenko, Alexis M. Temkin, Samir Parekh, Benjamin Tycko, Owen A. O'Connor
Journal: Blood
Blood (2011) 118 (20): 5506–5516.
https://doi.org/10.1182/blood-2011-02-336891
Published: 2011
Includes: Supplemental data
Journal Articles

Synergistic Combinations of Histone Deacetylase Inhibitors and Decitabine Induce a Unique Gene Expression and Epigenetic Profile In Models of Diffuse Large B-Cell Lymphoma

Matko Kalac, M.D., Ph.D., Enrica Marchi, M.D., Ph.D., Luigi Scotto, Ph.D., Jennifer Amengual, M.D., Venkatraman Seshan, Govind Bhagat, M.D., Netha Ulahannan, Violetta Leshchenko, Ph.D., Samir Parekh, M.D., Benjamin Tycko, M.D., Ph.D., Owen A. O'Connor, M.D., Ph.D.
Journal: Blood
Blood (2010) 116 (21): 435.
https://doi.org/10.1182/blood.V116.21.435.435
Published: 2010